Search

Author/Creator Carducci, Michael

1. Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study. Issue 1 (22nd October 2018)

Authors:
Amin, Asim; Plimack, Elizabeth R; Ernstoff, Marc S; Lewis, Lionel D; Bauer, Todd M; McDermott, David F; Carducci, Michael; Kollmannsberger, Christian; Rini, Brian I; Heng, Daniel Y C; Knox, Jennifer; Voss, Martin H; Spratlin, Jennifer; Berghorn, Elmer; Yang, Lingfeng; Hammers, Hans J
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 6:Issue 1(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Does Valproic Acid Induce Neuroendocrine Differentiation in Prostate Cancer?. (25th October 2010)

Authors:
Sidana, Abhinav; Wang, Muwen; Chowdhury, Wasim H.; Toubaji, Antoun; Shabbeer, Shabana; Netto, George; Carducci, Michael; Lupold, Shawn E.; Rodriguez, Ronald
Other Names:
Seiser Christian Academic Editor.
Journal:
Journal of biomedicine and biotechnology
Issue:
Volume 2011(2011)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study. Issue 1 (14th March 2019)

Authors:
Amin, Asim; Plimack, Elizabeth R.; Ernstoff, Marc S.; Lewis, Lionel D.; Bauer, Todd M.; McDermott, David F.; Carducci, Michael; Kollmannsberger, Christian; Rini, Brian I.; Heng, Daniel Y. C.; Knox, Jennifer; Voss, Martin H.; Spratlin, Jennifer; Berghorn, Elmer; Yang, Lingfeng; Hammers, Hans J.
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial. Issue 18 (16th July 2020)

Authors:
Motzer, Robert J.; Escudier, Bernard; George, Saby; Hammers, Hans J.; Srinivas, Sandhya; Tykodi, Scott S.; Sosman, Jeffrey A.; Plimack, Elizabeth R.; Procopio, Giuseppe; McDermott, David F.; Castellano, Daniel; Choueiri, Toni K.; Donskov, Frede; Gurney, Howard; Oudard, Stéphane; Richardet, Martin...
Journal:
Cancer
Issue:
Volume 126:Issue 18(2020)
Page Start:
4156
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate‐resistant prostate cancer: Results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance). Issue 20 (31st July 2013)

Authors:
Aggarwal, Rahul; Halabi, Susan; Kelly, William Kevin; George, Daniel; Mahoney, John F.; Millard, Frederick; Stadler, Walter M.; Morris, Michael J.; Kantoff, Philip; Monk, J. Paul; Carducci, Michael; Small, Eric J.
Journal:
Cancer
Issue:
Volume 119:Issue 20(2013)
Page Start:
3636
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate‐resistant prostate cancer. Issue 20 (31st July 2013)

Authors:
Aggarwal, Rahul; Halabi, Susan; Kelly, William Kevin; George, Daniel; Mahoney, John F.; Millard, Frederick; Stadler, Walter M.; Morris, Michael J.; Kantoff, Philip; Monk, J. Paul; Carducci, Michael; Small, Eric J.; for the Alliance for Clinical Trials in Oncology
Journal:
Cancer
Issue:
Volume 119:Issue 20(2013)
Page Start:
3636
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗